Georgian Partners leads $35 mln Series C financing of Glooko
Glooko, a U.S. diabetes data management platform, has secured $35 million in Series C financing. The round was led by Canadian growth equity firm Georgian Partners and joined by new and existing investors, including Canaan Partners, Medtronic and Social Capital. Founded in 2010, Glooko is a developer of remote patient monitoring technology.
28 June 2017•3 mins read
